The Enzyme Inhibitors Market is on a growth trajectory, with projections estimating a market size of USD 47.95 billion by 2035, up from USD 26.97 billion in 2024. This growth signifies a compound annual growth rate (CAGR) of 5.37%, underlining the increasing demand for innovative therapies that address chronic health conditions. The surge in investments in biopharmaceutical R&D serves as a...